NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.40% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 5.32% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.30% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.89% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.79% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.79% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.78% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 4.57% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.47% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.55% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.44% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.38% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 3.08% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| VCEL | Vericel Corp Ord | Healthcare | Biotechnology | 3.02% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 2.88% |